People living with HIV affected by advanced HIV disease are dying due to government inaction
In Nigeria, a treatable disease is becoming a death sentence not because medicine is unavailable to the world, but because it has not reached the shelves where the dying wait. The Network of People Living with HIV/AIDS has raised the alarm over a nationwide tuberculosis drug shortage rooted in the Federal government's failure to honor its own funding commitments — a bureaucratic lapse with biological consequences. For those living with HIV, where tuberculosis is already the leading cause of death, an interrupted supply chain is not an inconvenience but a verdict. The crisis asks an old and painful question: when a government knows lives depend on action, what does inaction mean?
- TB medicines, diagnostics, and related supplies have disappeared from facilities across Nigeria, leaving thousands of patients — especially those living with HIV — without treatment for a disease their bodies cannot survive alone.
- Every day without medication is not a pause but a progression: illness deepens, bacteria adapt, and the window for effective treatment narrows toward closure.
- The Federal government's failure to release counterpart funding and fulfill procurement commitments has been identified as the direct cause, transforming a solvable supply problem into a preventable mass casualty event.
- Drug-resistant tuberculosis — harder to treat, more expensive, sometimes impossible to cure — looms as the next crisis if full treatment courses remain inaccessible to interrupted patients.
- NEPWHAN is demanding the Federal Executive Council declare an emergency, approve immediate funding, and begin procurement now, before the shortage compounds into a resistance epidemic that will burden Nigeria's health system for a generation.
Nigeria is running out of tuberculosis drugs, and the people who depend on them are dying. The Network of People Living with HIV/AIDS in Nigeria sounded the alarm this week, warning of a public health emergency as essential TB medicines and diagnostics have vanished from facilities across the country. The shortage strikes hardest at people living with HIV, for whom tuberculosis is the single leading cause of death.
Abdulkadir Ibrahim, NEPWHAN's national coordinator, laid out the stakes at a briefing in Abuja. Nigeria already carries one of the world's heaviest TB burdens. When drugs run out, treatment stops — and patients do not simply wait. Their illness worsens, their bodies develop resistance to the medicines that might have saved them, and the disease spreads to others. The root cause is not mysterious: the Federal government has failed to meet its own counterpart funding commitments, leaving procurement undone and shelves empty.
Steve Aborishade of AIDS Healthcare Foundation named the longer-term danger. Incomplete treatment courses allow TB bacteria to adapt and mutate into drug-resistant strains — harder to treat, more expensive, sometimes beyond reach. Nigeria has not yet crossed that threshold, but the path there is short without urgent intervention.
NEPWHAN is calling on the Federal Executive Council to declare the shortage a national health priority and approve emergency procurement funding immediately. The appeal is urgent because the arithmetic is simple: people are dying from a treatable disease, and the longer the government waits, the more it will inherit — in lives lost, in resistant strains, and in a health system strained by consequences that were entirely preventable.
Nigeria is running out of tuberculosis drugs, and the people who depend on them are dying. The Network of People Living with HIV/AIDS in Nigeria sounded the alarm this week, warning that the country faces a public health emergency as essential TB medicines, diagnostics, and related supplies have vanished from shelves across the nation. The shortage is not a minor supply hiccup. It is a cascading crisis that threatens thousands of lives, particularly among people living with HIV, for whom tuberculosis remains the single leading cause of death.
Abdulkadir Ibrahim, the national coordinator of NEPWHAN, laid out the stakes plainly during a briefing with journalists in Abuja. Nigeria already carries one of the heaviest tuberculosis burdens in the world. The current medicine shortage transforms that existing crisis into something more acute and more deadly. When TB drugs run out, treatment stops. When treatment stops, patients do not simply wait for supplies to resume. Their illness deepens. Their bodies develop resistance to the very medicines that might have saved them. The virus spreads to others. People die from a disease that is treatable.
The root cause is not mysterious. The Federal government has failed to adequately finance TB programs and has not met its own counterpart funding commitments to the national TB response. Money that should have been allocated was not allocated. Procurement that should have happened did not happen. The result is that people living with advanced HIV disease—already immunocompromised, already fragile—are losing access to the drugs they need to survive a secondary infection that their bodies cannot fight alone.
Steve Aborishade, senior advocacy and marketing manager at AIDS Healthcare Foundation, framed the longer-term danger. TB is a life-threatening disease. But more than that, the current stockout creates conditions for something worse: drug-resistant tuberculosis. When patients cannot access full courses of treatment, the bacteria adapt. They mutate. They become immune to the drugs that once worked. Once that happens, treatment becomes harder, more expensive, and sometimes impossible. Nigeria is not there yet. But without urgent action, the country will arrive at that point.
Treatment interruptions do more than kill individuals. They increase the risk of severe illness across populations. They enable continued transmission within vulnerable communities. They create preventable deaths—deaths that would not occur if the supply chain worked, if the government had released the funds, if procurement had moved forward on schedule.
NEPWHAN is calling on the Federal government to declare the TB commodity shortage a public health priority requiring immediate intervention. The organization is urging the Federal Executive Council to approve emergency funding and release it now, so that procurement can begin immediately. The language is urgent because the situation is urgent. People are dying. The clock is running. Without intervention, Nigeria will face not only higher mortality rates but the emergence of drug-resistant TB strains that will haunt the health system for years to come.
Citações Notáveis
Nigeria carries one of the highest burdens of TB globally, and the current shortage of TB medicines and diagnostics represents a major public health emergency threatening thousands of lives— Abdulkadir Ibrahim, National Coordinator of NEPWHAN
The country might begin to experience high cases of TB drug resistance as a result of the present stockout— Steve Aborishade, Senior Advocacy and Marketing Manager at AIDS Healthcare Foundation
A Conversa do Hearth Outra perspectiva sobre a história
Why does TB hit people with HIV so much harder than the general population?
When your immune system is already compromised by HIV, your body cannot fight off TB on its own. TB becomes not just a serious infection—it becomes the thing that kills you. For someone with advanced HIV disease, TB is the leading cause of death. It's the opportunistic infection that their body simply cannot repel.
So when the drugs run out, what actually happens to a patient in treatment?
Their treatment stops. They're still sick. The bacteria is still in their lungs. And now they're not taking medicine to suppress it. Over time, if they don't get back on treatment, the bacteria adapts. It learns to survive the drugs. That's how you get drug resistance—not from one person, but from thousands of people unable to complete their courses.
Is this a new problem, or has Nigeria been struggling with TB supply for a while?
Nigeria has always carried a heavy TB burden. But this particular stockout—the complete absence of drugs and diagnostics across the country—that's the emergency they're naming now. It's the moment when a chronic problem becomes acute.
What does the government need to do, concretely?
Release money. The Federal Executive Council needs to approve emergency funding and get it into the procurement system immediately. Without that, there's no way to buy the drugs, no way to get them distributed, no way to restart treatment for people who've had to stop.
And if they don't?
Then you're looking at higher death rates among people living with HIV. You're looking at the emergence of drug-resistant TB strains. You're looking at a public health crisis that gets worse, not better, over the next year or two.